VF
VNDA icon

Virtu Financial’s Vanda Pharmaceuticals VNDA Stock Holding History

Virtu Financial’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Sell
10,210
-118,075
-92% -$771K ﹤0.01% 1192
2026
Q1 		$886K Buy
+128,285
New +$989K 0.04% 348
2025
Q3 		– Sell
-12,455
Closed -$59K – 2135
2025
Q2 		$59K Sell
12,455
-3,148
-20% -$13.8K ﹤0.01% 1122
2025
Q1 		$72K Buy
+15,603
New +$72.7K ﹤0.01% 965
2024
Q4 		– Sell
-21,713
Closed -$102K – 2095
2024
Q3 		$102K Sell
21,713
-43,435
-67% -$233K 0.01% 907
2024
Q2 		$368K Buy
65,148
+18,179
+39% +$93.9K 0.03% 538
2024
Q1 		$193K Buy
+46,969
New +$188K 0.01% 800
2021
Q2 		– Sell
-10,142
Closed -$152K – 2112
2021
Q1 		$152K Buy
+10,142
New +$164K 0.01% 1188

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's VNDA Position: Q2 2026 in Review

Virtu Financial reduced its Vanda Pharmaceuticals (VNDA) stake by 92% in Q2 2026, selling an estimated $771K and leaving 10,210 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Virtu Financial first reported a position in VNDA in Q1 2021 and has held it in 8 quarters since. The position peaked at $886K in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Virtu Financial held 10,210 shares of Vanda Pharmaceuticals worth $62K as of Q2 2026.
  • Virtu Financial sold 118,075 Vanda Pharmaceuticals shares in Q2 2026, an estimated $771K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1192 holding.
  • Virtu Financial first reported a position in Vanda Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • Virtu Financial's Vanda Pharmaceuticals position peaked at $886K in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.